Basophilia
Basophilia signals immune system activation and marrow dynamics—often from allergy, chronic inflammation, parasitic infection, or myeloproliferative disease (e.g., CML). Measuring basophils (percentage) and absolute basophil count clarifies severity and context. At Superpower, we test Basophils and Absolute Basophils to detect and monitor basophilia.
DIC
Biomarker testing helps detect Disseminated Intravascular Coagulation—a dangerous imbalance of clotting and bleeding—early and track its trajectory. It reveals systemic inflammation and consumption of blood components. At Superpower, we test Platelets, WBC, and CRP for DIC to monitor hemostasis, immune activation, and inflammatory burden.
Eosinophilia
Eosinophilia signals immune activation, often from allergies, infections, or inflammatory disease. Measuring eosinophils reveals how your innate immune system is behaving. At Superpower, we test Eosinophils and Absolute Eosinophils to quantify burden (relative percentage and absolute count) and flag clinically significant eosinophilia.
Hemolytic Anemia
Biomarker testing pinpoints accelerated red cell breakdown and the body’s compensation. At Superpower, we test for Hemoglobin, RDW/MCV Ratio, Bilirubin Indirect, and BAR for Hemolytic Anemia to reveal oxygen transport, cell size variability, heme catabolism, and hemolysis signal dynamics.
Leukemia
Leukemia disrupts blood cell production and immune balance. Biomarker testing flags abnormal counts, sizes, and maturation patterns that signal marrow stress or malignant clones. At Superpower, we test WBC, Neutrophils, Lymphocytes, Monocytes, and RDW for leukemia to detect leukocytosis, cytopenias, and anisocytosis—early clues to disease.
Lymphopenia
Lymphopenia indicates too few lymphocytes, signaling reduced adaptive immune reserve and higher vulnerability to infections. Testing quantifies immune cell availability and recovery capacity. At Superpower, we assess Lymphocytes and Absolute Lymphocytes (absolute lymphocyte count, ALC) to detect lymphopenia early and track immune system integrity over time.
MGUS
MGUS reflects abnormal plasma-cell protein production that can signal early dysregulation of immune and hematologic systems. Biomarker testing screens for this silent process. At Superpower, we monitor Total Protein, Globulin, and the Albumin/Globulin (A/G) ratio to flag disproportionate globulins that warrant clinical confirmation.
Multiple Myeloma
Biomarker testing clarifies plasma cell activity, immunoglobulin production, and inflammation, helping detect and monitor Multiple Myeloma. At Superpower, we test for Albumin, Total Protein, Globulin, A/G ratio, and ESR to reflect protein balance, paraproteins, and systemic inflammation.
Neutropenia
Neutropenia weakens frontline immune defense, increasing infection risk. Biomarker testing clarifies marrow output and immune readiness by measuring circulating neutrophils. At Superpower, we test for Neutrophils and Absolute Neutrophils (absolute neutrophil count, ANC) to detect severity and pattern of neutropenia, guiding interpretation of immune system resilience.
Polycythemia Vera
Polycythemia Vera is a marrow-driven overproduction of blood cells, thickening blood and straining circulation and oxygen delivery. Biomarker testing flags this physiology early. At Superpower, we test RBC, Hemoglobin, Hematocrit, Platelet Count, and WBC to assess cell mass, concentration, and panmyelosis, guiding further evaluation.
Thrombocytopenia
Thrombocytopenia testing clarifies bleeding risk and how your blood-forming system is performing. Platelet Count shows circulating platelets essential for clotting; MPV (mean platelet volume) helps distinguish decreased production from increased destruction. At Superpower, we test for Platelet Count and MPV for Thrombocytopenia to map hemostasis and marrow dynamics.
Thrombocytosis
Thrombocytosis reveals heightened platelet production and activation, affecting clotting dynamics and inflammatory signaling. Testing clarifies whether the elevation is reactive or primary (myeloproliferative). At Superpower, we test for Platelet Count, MPV, CRP for Thrombocytosis.
Thrombophilia
Thrombophilia testing clarifies your blood’s tendency to clot, revealing pro-thrombotic physiology. At Superpower, we assess Homocysteine, CRP, Platelets, and the neutrophil-to-lymphocyte ratio (NLR) to map inflammation, endothelial stress, and hemostatic balance—key drivers of venous and arterial thrombosis risk.
